Background Image
Previous Page  36 / 38 Next Page
Information
Show Menu
Previous Page 36 / 38 Next Page
Page Background

35

35

Diretrizes AMB

occlusive events in patients with ischemic stroke. JAMA 2004;291:576-

84.19.

19.Pengo V, Ruffatti A,Legnani C, Gresele P, Barcellona D, Erba N, et

al. Clinical course of high-risk patients diagnosed with

antiphospholipid syndrome. J Thromb Haemost 2010;8:237-42.

20. Lefèvre G, Lambert M, Bacri JL, Dubucquoi S, Quemeneur T,

Caron C, et al. Thrombotic events during long-term follow-up of

obstetric antiphospholipid syndrome patients. Lupus 2011;20:861-5.

21. Cervera R, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S,

Kiss E, et al. Morbidity and mortality in the antiphospholipid

syndrome during a 5-year period: a multicentre prospective study of

1000 patients. Ann Rheum Dis 2009;68:1428-32.

22.

Erkan D, Merrill JT, Yazici Y, Sammaritano L, Buyon JP, Lockshin

MD. High thrombosis rate after fetal loss in antiphospholipid

syndrome: effective prophylaxis with aspirin. Arthritis Rheum

2001;44:1466-7.

23..Gris JC, Bouvier S, Molinari N, Galanaud JP, Cochery-Nouvellon

E, Mercier E, et al. Comparative incidence of a first thrombotic event

in purely obstetric antiphospholipid syndrome with pregnancy loss:

the NOH-APS observational study. Blood 2012;119:2624-32.

24. Cowchock S, Reece EA. Do low-risk pregnant women with

antiphospholipid antibodies need to be treated? Organizing Group of

the Antiphospholipid Antibody Treatment Trial. Am J Obstet

Gynecol 1997;176:1099-100.

25. Bergrem A, Jacobsen EM, Skjeldestad FE, Jacobsen AF, Skogstad

M, Sandset PM. The association of antiphospholipid antibodies with

pregnancy-related first time venous thrombosis--a population-based

case-control study. Thromb Res 2010;125:e222-7.

26. Quenby S, Farquharson RG, Dawood F, Hughes AM, Topping J.

Recurrent miscarriage and long-term thrombosis risk: a case-control

study. Hum Reprod 2005;20:1729-32.

27. Martinez-Zamora MA, Peralta S, Creus M, Tassies D, Reverter JC,

Espinosa G, et al. Risk of thromboembolic events after recurrent

spontaneous abortion in antiphospholipid syndrome: a case-control

study. Ann Rheum Dis 2012;71:61-6.

28. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM,

Vandvik PO, et al. VTE, thrombophilia, antithrombotic therapy, and

pregnancy: Antithrombotic Therapy and Prevention of Thrombosis,